Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Kate Guilfoyle et al.|Clinical & Translational Immunology|2021Cited by 62
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Unknown|2020Cited by 15
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirusAndrew Young, Keith J. Chappell, Sharada Kolekar et al.|PLoS Pathogens|2025Cited by 8
Rapid Application of the Molecular Clamp Platform for SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|SSRN Electronic Journal|2020Cited by 1